1. Triptolide Inhibits the Biological Processes of HUVECs and HepG2 Cells via the Serine Palmitoyltransferase Long Chain Base Subunit 2/Sphingosine-1-Phosphate Signaling Pathway
   Lulu Jia et al, 2022, Disease Markers CrossRef
2. Natural products targeting autophagy and apoptosis in NSCLC: a novel therapeutic strategy
   Peiyi Qin et al, 2024, Frontiers in Oncology CrossRef
3. A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
   Pengyu Yao et al, 2024, Frontiers in Immunology CrossRef
4. A Bibliometric Analysis of Triptolide and the Recent Advances in Treating Non–Small Cell Lung Cancer
   Quancheng Yang et al, 2022, Frontiers in Pharmacology CrossRef
5. Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2‐mediated PI3K/AKT pathway
   Jiankun Ren et al, 2024, Chemical Biology & Drug Design CrossRef
6. Triptolide Shows High Sensitivity and Low Toxicity Against Acute Myeloid Leukemia Cell Lines Through Inhibiting WSTF-RNAPII Complex
   Di Kang et al, 2022, Frontiers in Oncology CrossRef
7. Triptolide alleviates collagen‐induced arthritis in mice by modulating Treg/Th17 imbalance through the JAK/PTEN‐STAT3 pathway
   Yao Huang et al, 2023, Basic & Clinical Pharmacology & Toxicology CrossRef